Effect of the probiotic Escherichia coli Nissle 1917 on serum levels of NADPH oxidase-2 and lipopolysaccharide in patients with Alzheimer's disease
- 1 July 2025
- journal article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 106 (2) , 774-782
Abstract
Background: Intestinal bacteria-derived molecules, such as lipopolysaccharide (LPS) produced by Gram-negative bacteria, can translocate into the bloodstream through the gut wall, contributing to inflammation and neurodegeneration via oxidative stress mechanisms. NADPH oxidase-2 activation and superoxide anion production play a key role in this process, particularly in conditions like Alzheimer's disease (AD), where gut permeability is often altered. This study hypothesized that modulating gut microbiota with the probiotic Escherichia coli Nissle 1917 (ECN) could mitigate LPS translocation and its associated inflammatory effects. Objective: To evaluate the effect of daily ECN administration on serum LPS levels in elderly AD patients. Methods: A randomized, double-blind, placebo-controlled trial was conducted with 40 mild AD patients, with 39 completing the study (20 ECN, 19 placebo). Participants received ECN (2.5–25 × 10^9 CFU/capsule) or placebo for six weeks. The serum activity of soluble NOX2-dp (sNOX2-dp), hydrogen peroxide (H 2 O 2 ) production, tumor necrosis factor (TNF)-α levels and LPS was evaluated, while serum zonulin levels were measured to assess gut permeability. Results: The ECN group showed significant reductions in sNOX2-dp (−21%), H 2 O 2 (−27%), TNF-α (−18%), LPS (−15%), and zonulin (−35%), along with improved Mini-Mental State Examination (MMSE) scores. No significant changes were seen in the placebo group. Mixed ANOVA showed significant time-by-treatment interactions for zonulin (p = 0.04) and MMSE (p < 0.001). Changes in LPS correlated with changes in zonulin (Rs = 0.408, p = 0.011). Conclusions: ECN may strengthen gut barrier function, reduce endotoxemia, and attenuate inflammation in AD, though larger studies are needed to confirm these findings.Keywords
Funding Information
- PNRR (PNRR—M4C2- I1.3 Project PE_00000019 “HEAL ITAL)
This publication has 37 references indexed in Scilit:
- Potential links between platelets and amyloid-β in the pathogenesis of Alzheimer's disease: Evidence from in vitro, in vivo, and clinical studiesExperimental Neurology, 2024
- Endothelial dysfunction, oxidative stress and low-grade endotoxemia in COVID-19 patients hospitalised in medical wardsMicrovascular Research, 2023
- Activation of neuronal NADPH oxidase NOX2 promotes inflammatory neurodegenerationFree Radical Biology and Medicine, 2023
- Oxidative stress: The core pathogenesis and mechanism of Alzheimer’s diseaseAgeing Research Reviews, 2022
- The Relationship Between the Gut Microbiome and Neurodegenerative DiseasesNeuroscience Bulletin, 2021
- Imbalance of Microglial TLR4/TREM2 in LPS-Treated APP/PS1 Transgenic Mice: A Potential Link Between Alzheimer’s Disease and Systemic InflammationNeurochemical Research, 2019
- Microbiota-Brain-Gut Axis and Neurodegenerative DiseasesCurrent Neurology and Neuroscience Reports, 2017
- Systemic LPS causes chronic neuroinflammation and progressive neurodegenerationGlia, 2007
- Rating chronic medical illness burden in geropsychiatric practice and research: Application of the Cumulative Illness Rating ScalePsychiatry Research, 1992
- “Mini-mental state”Journal of Psychiatric Research, 1975